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Background: Brunner’s gland hamartoma is a rare tumor, predominantly found in the fifth to sixth decades of life.
Generally, it is a single pedunculated polyp, rarely larger than 5 cm. Asymptomatic cases are found incidentally, but
cases with a large polyp tend to have gastrointestinal bleeding and/or obstructive symptoms. Polyp size increases
in a time-dependent manner, however, the growth mechanism is unknown. We report a Japanese male case in his
mid-twenties with an over 6 cm sized polyp.
Case presentation: A 26-year-old man presented black stools and anemia. Endoscopic examination revealed a
large pedunculated polyp at gastroduodenal junction. The polyp, subsequently resected by distal gastrectomy, was
lobulated with random surface erosions and sized 6.4 × 3 cm. Histological examination revealed that the polyp
arose from duodenal mucosa and was composed of hyperplastic Brunner’s glands in lobules separated by
fibromuscular septa, associated with lymphocytic infiltrate and lymphoid follicles. No evidence of malignancy was
found. Thus, the lesion was diagnosed as Brunner’s gland hamartoma. Further immunohistochemical studies
indicated that gastric foveolar metaplasia is associated with surface epithelium covering upper two thirds of the
polyp, showing immunohistochemical positivity for mucin 5 AC (MUC5AC). Below the metaplastic surface
epithelium, Brunner’s glands had high proliferative activity (MIB-1 labeling index: 7.9%). The similar staining pattern
was observed at surface erosive sites (MIB-1 labeling index in Brunner’s glands: 9%). On the other hand, surface
epithelium in the lower side of the polyp still preserved intestinal nature, containing CDX2-positive nuclei and
MUC2-positive goblet cells. Brunner’s glands below the surface epithelium with intestinal characteristics showed
low proliferative activity (MIB-1 labeling index: 0.77%).
Conclusion: Proliferative activity of Brunner’s glands was high at the sites with surface erosion and also below the
epithelium showing gastric foveolar metaplasia. As gastric foveolar metaplasia occurs along with a mucosal repair
process in the duodenum, mucosal damages underlay the hamartomatous proliferation of Brunner’s glands and
eventually resulted in a formation of large polypoid mass in this case.
Keywords: Brunner’s gland hamartoma, Brunner’s glands, Gastric foveolar metaplasia, MUC5AC, MIB-1,
Mucosal damage* Correspondence: mayumi_akaki@med.miyazaki-u.ac.jp
1Clinical Laboratory, University of Miyazaki Hospital, 5200 Kihara, Kiyotake,
Miyazaki, Miyazaki 889-1692, Japan
2Section of Oncopathology and Regenerative Biology, Department of
Pathology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake,
Miyazaki, Miyazaki 889-1692, Japan
Full list of author information is available at the end of the article
© 2014 Akaki et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Figure 1 Endoscopic image and gross findings. (A) Endoscopic
image showing a large polyp at gastroduodenal junction. The polyp
head was incarcerated toward duodenal lumen. Hemorrhage was
noted in part of the surface. (B) Surgically resected specimen
showing a single lobulated and pedunculated polyp. Hemorrhage
and erosion are associated. (C) Cut surface of the polyp is white and
solid showing lobular structure and a broad fibrous stalk.
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Brunner’s gland hamartoma is a rare tumor-like lesion,
predominantly seen in the fifth to sixth decades of life.
This lesion is generally a single pedunculated polyp, with
an average size of 2 cm, rarely larger than 5 cm, and lo-
cates in the first portion of duodenum [1]. Its pathogen-
esis is unknown and malignant change is rarely observed
[2]. Most cases are asymptomatic and found incidentally.
Cases with a large-sized polyp tend to have gastrointes-
tinal bleeding and/or obstructive symptoms. According
to studies with long-term follow-up, polyp size gradually
increases in a time-dependent manner [3,4].
We experienced a 26 year-old male case with an over
6 cm sized polyp at gastroduodenal junction, investi-
gated histological and immunohistochemical characteris-
tics of the lesion, and report here.
Case presentation
A 26-year-old man presented black stools and anemia.
He had not taken any medication and had no specific
family or past medical history. His height and weight
were 172.3 cm and 93.4 kg (the body mass index was
31.5 kg/m2). His body temperature was 36.7°C, blood
pressure was 137/77 mmHg and radial pulse rate was
80 beats/min and regular. Complete blood count showed
the red blood cell count of 326 × 104/μl, hemoglobin
concentration of 8.6 g/dl (reference range: 13.5 to 17.6 g/dl),
and mean corpuscular volume of 87 fl. Serum chemistry
showed that hemoglobin A1c was 4.2% (National Glycohe-
moglobin Standardization Program number). Endoscopic
examination of the upper digestive tract revealed a large
pedunculated polyp arising from gastroduodenal junction,
close to pyloric ring on the side between minor curvature
and anterior wall (Figure 1A). The head of the polyp
was incarcerated toward duodenal lumen. The lower
side of the polyp showed hemorrhage in part. The stalk
was too thick to be removed by endoscopic mucosal re-
section. Instead, distal gastrectomy with lymph node
dissection was performed. No metastasis was found in
the dissected lymph nodes.
The postoperative period was uneventful that the
hemoglobin concentration gradually increased and be-
came 11.6 g/dl on day 12. He was subsequently dis-
charged without any complications and was in good
health with 1 year follow-up.
The surgically resected specimen showed a lobulated
polyp sized 6.4 × 3 cm (Figure 1B) and the cut surface
was solid and white (Figure 1C). Histologically, the stalk
of the polyp projected from duodenal mucosa, not
pyloric mucosa. In the lesion, marked proliferation of
Brunner’s glands was noted showing lobular structures
separated by fibromuscular septa (Figure 2A). Acini and
ducts were well preserved (Figure 2C) and cystically dilated
ducts were scattered (Figure 2B). Lymphocytic infiltrate
Figure 2 Histological findings of the resected specimen.
(A) Hyperplastic Brunner’s glands in lobules are separated by
fibromuscular septa. HE stain, 40× (B) Lymphocytic infiltrate is
observed and a lymphoid follicle is formed between lobules of
Brunner’s glands at the center. Arrow indicates a cystically dilated
duct. HE stain, 40× (C) Acini and ducts are well-preserved without
nuclear atypia. HE stain, 200×.
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mation was intermingled in and between the lobules of hy-
perplastic Brunner’s glands (Figure 2B). The upper two
thirds of the polyp was covered by a surface epithelium his-
tologically similar to gastric foveolar epithelium (Figure 3A),randomly with surface erosions (Figure 3E). No evidence
of malignancy was found within the specimen (Figure 2C).
These findings suggested that the lesion was composed
of normal tissue elements of duodenal mucosa and sub-
mucosa, but formed a disorganized aberrant mass. Thus,
we diagnosed this lesion as Brunner’s gland hamartoma.
Helicobacter pylori infection was not detected in Giemsa
stain.
Then, we sought to clarify the possible pathogenesis
of this lesion by immunohistochemical analyses for mucin
phenotypes, CDX2 expression and MIB-1 labeling. The
surface epithelium resembling gastric foveolar epithelium
was positive for MUC5AC (Figure 3B), indicating gas-
tric foveolar metaplasia, while the epithelium in deeper
portion and Brunner’s glands were positive for MUC6
(Figure 3C). The epithelial cells at the transition zone be-
tween MUC5AC- and MUC6-positive areas showed con-
comitant expression of MUC5AC and MUC6 (Figure 3B
and C). These results confirmed that the surface epithe-
lium differentiated towards gastric foveolar epithelium but
preserved intestinal epithelial nature in the deeper por-
tion. Interestingly, the MUC5AC-positive epithelium and
adjacent MUC6-positive epithelium were diffusely positive
for MIB-1 (Figure 3D), and the Brunner’s glands beneath
them showed high MIB-1 labeling index (7.9%; Figures 3D
and 4A).
The similar staining pattern was observed in the area
with surface erosion (Figure 3E-H), where most of
surface epithelium was lost, but the deeper portion of
the epithelium was minimally left (Figure 3E), showing
MUC5AC/MUC6 double positivity (Figure 3F and 3G)
with significantly high MIB-1 labeling (Figure 3H). Mod-
erately high MIB-1 labeling of Brunner’s glands (9%) was
accompanied (Figures 3H and 4B).
On the other hand, surface epithelium in the lower
part of the polyp showed a villous structure containing
goblet cells without apparent gastric foveolar metaplasia
(Figure 3I). Immunohistochemically, positivity of MUC5AC
staining decreased in the lower one third of the polyp,
particularly on the distal side. In the same area, CDX2-
positive nuclei (Figure 3J) and MUC2-positive goblet cells
(Figure 3K) were observed at the surface epithelium
showing intestinal nature. Below the surface epithelium
preserving intestinal nature, Brunner’s glands had less
proliferative activity with low MIB-1 labeling index (0.77%)
(Figures 3L and 4C). These results suggest that gastric
foveolar differentiation is possibly related with the observed
proliferative activity of Brunner’s glands.
Conclusions
Brunner’s gland hamartoma is generally a single peduncu-
lated polyp composed of hyperplastic Brunner’s glands
with a variable amount of ducts, smooth muscles, fibrous
tissue, adipose tissue, and lymphocytes. This lesion is
Figure 3 Immunohistochemical findings of the resected specimen. Duodenal mucosa in the upper part of the polyp (A - D), with erosion
(E - H), and in the lower part of the polyp (I - L) are shown in HE stain (A, E, and I), MUC5AC (B and F), MUC6 (C and G), MIB-1 (D, H and L),
CDX2 (J), and MUC2 (K) immunostains. Surface epithelium in the upper part of the polyp is histologically similar to gastric foveolar epithelium
and immunohistochemically positive for MUC5AC, suggesting gastric foveolar metaplasia (B), and the epithelium in the deeper portion and
Brunner’s glands are positive for MUC6 (C). This area shows high MIB-1 labeling (D). The similar staining pattern is observed in the mucosa with
erosion (E - H). Surface epithelium in the lower part of the polyp shows a villous structure, containing CDX2-positive nuclei (J) and MUC2-positive
goblet cells (K), suggesting preservation of the intestinal nature. MIB-1-positive Brunner’s glands are inconspicuous in this area (L). All images are
40× magnification.
Figure 4 MIB-1 labeling in Brunner’s glands. Representative immunostain images of Brunner’s glands below surface epithelium associated
with gastric foveolar metaplasia (A), below erosion (B), and below surface epithelium preserving intestinal nature (C) are shown. Brunner’s glands
in (C) are rarely positive for MIB-1, compared to those in (A) and (B). All images are 100× magnification.
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ever, some dispute using the latter because this lesion
is usually an admixture of normal tissues without cyto-
logical atypia.
Brunner’s gland hamartoma is predominantly found in
those in their fifties to sixties. Several cases in their
twenties have been reported with or without describing
the lesion size, and to the best of our knowledge, only two
cases (23- and 20-year-old women) have been reported
mentioning their unusually large polyp size, 5.5 cm exam-
ined histologically and 7 cm observed by endoscopy [5,6].
The major disadvantage having a large polyp is that a
benign lesion may be misdiagnosed and over-treated as
malignancy. In the past, a 60-year-old male case was re-
ported that Brunner’s gland hyperplasia forming a 5.5 cm
polyp at duodenal bulb was treated by duodenocephalo-
pancreatectomy [7]. When a large polyp is noted at duo-
denum, it is important for clinicians to have Brunner’s
gland hamartoma as a differential diagnosis, even with the
rarity of the disease.
In our immunohistochemical study, proliferative activity
of Brunner’s glands was high beneath the epithelium
showing gastric foveolar metaplasia. Gastric foveolar
metaplasia seems to be a common finding in Brunner’s
gland hamartoma [2], and also associated with dysplastic
changes in Brunner’s gland hyperplasia [8,9]. One of the
duodenal diseases frequently with gastric foveolar meta-
plasia is duodenal ulcer. In a duodenal ulcer lesion, muco-
sal repair mechanism initially generates epithelium with
gastric foveolar metaplasia and then expands Brunner’s
glands [10]. Although how Brunner’s gland hamartoma
grows is unclear, it is reasonable to assume that repeated
mucosal damages activate mucosal repair mechanism, fa-
cilitating a proliferation of Brunner’s glands accompanied
by surface gastric foveolar metaplasia.
Kim, et al., recently reported histology and mucin ex-
pression in Brunner’s gland hamartoma and hyperplasia
[2]. They showed that Brunner’s gland hamartoma/hyper-
plasia lesions tended to be larger with surface epithelial
change, such as erosion, ulcer, and gastric foveolar meta-
plasia, which is in accordance with our hypothesis that
mucosal damage facilitates Brunner’s gland proliferation.
Although proliferative activity of Brunner’s glands near
surface epithelium was not described in their study,
slightly increased proliferative activities in atypical glands
and sclerotic glandular foci were reported with MIB-1 la-
beling index of 3% and 2%, respectively. The sclerotic
glandular foci are probably old lesions in the mucosal re-
pair process, since the foci were found in 63.2% of the
cases with surface epithelial changes but not in the cases
without surface epithelial change [2].
Considering possible causes of mucosal damage, mech-
anical stimuli, Helicobacter pylori infection, and hyperaci-
dic environment in duodenum have been suggested. Thelatter two have been postulated to be involved in the devel-
opment of Brunner’s gland hamartoma [11,12]. Heli-
cobacter pylori infection was reported in some cases of
Brunner’s gland hamartoma [3], but not observed in the
other cases [4]. The infection is unlikely to be essential
for a hamartomatous proliferation of Brunner’s glands.
Hyperacidity can induce hyperplastic change of Brunner’s
glands, which secrete alkaline mucin to buffer gastric
acid. Franzin, et al., demonstrated hyperacidic state in
patients with Brunner’s gland hamartoma [12]. Inter-
estingly, gastric foveolar metaplasia has been regarded
as a protective change of the duodenal mucosa against
hyperacidity [13].
In summary, we report a case of large Brunner’s gland
hamartoma in a young (26-year-old) patient. Our immuno-
histochemical results suggest that mucosal damage under-
lies the hamartomatous proliferation of Brunner’s glands.
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